Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/STAR stock hub

NSE/STAR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/STARis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
106.6B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/STAR
In the news

Latest news · NSE/STAR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.9
P25 24.9P50 32.4P75 45.7
Trailing P/E20.8
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC13.5
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/STAR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
10
Currency
INR
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
3,301
Employees Change
236%
Employees Change Percent
7.7
Enterprise value
INR 123.3B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE939A01011
Last refreshed
2026-05-10
Market cap
INR 106.6B
Price
INR 1,169
Price currency
INR
Rev Per Employee
14,315,680.1x
Sector
Healthcare
Sic
2834
Symbol
nse/STAR
Website
https://www.strides.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
4.8%
EV Earnings
24.1x
EV/EBIT
17.45x
EV/EBITDA
14.02x
EV/Sales
2.61x
Forward P/E
16.87x
P/B ratio
3.8x
P/E ratio
20.85x
P/S ratio
2.26x
PE Ratio10 Y
87.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
14.9%
EBITDA Margin
18.01%
Gross margin
56.2%
Gross Profit
INR 26.6B
Gross Profit Growth
1.93%
Gross Profit Growth Q
8.64%
Gross Profit Growth3 Y
13.78%
Gross Profit Growth5 Y
8.81%
Net Income
INR 5.1B
Net Income Growth
-85.51%
Net Income Growth Q
129.81%
Net Income Growth Quarters
2%
Net Income Growth Years
3%
Net Income Growth5 Y
94.38%
Pretax Margin
13.27%
Profit Margin
10.82%
Profit Per Employee
INR 1.5M
Profitable Years
1
Roa5y
2.66
Roe5y
-1.71
ROIC
13.49
Roic5y
5.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
11.2%
Cagr15y
22.88%
Cagr1y
81.17%
Cagr20y
17.78%
Cagr3y
102.46%
Cagr5y
29.29%
Div CAGR10
0%
Div CAGR3
38.67%
Div CAGR5
9.86%
EPS Growth
-85.54
EPS Growth Q
129.5
EPS Growth Quarters
2
EPS Growth Years
3
EPS Growth5 Y
93.35
Revenue Growth
3.19x
Revenue Growth Q
3.55x
Revenue Growth Quarters
10x
Revenue Growth Years
3x
Revenue Growth3 Y
9.82x
Revenue Growth5 Y
9.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 2.3B
Debt
INR 18.4B
Debt EBITDA
INR 2.1
Debt Equity
INR 0.66
Equity
INR 28B
Interest Coverage
4.83
Net Cash
INR -16.2B
Net Cash By Market Cap
INR -15.16
Net Debt EBITDA
INR 1.9
Net Debt Equity
INR 0.58
Tangible Book Value
INR 15.1B
Tangible Book Value Per Share
INR 164
WACC
6.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.23%
Dividend Growth
60%
Dividend Growth Years
2%
Dividend per share
INR 4
Dividend Years
3
Dividend Yield
0.35%
Ex Div Date
2025-07-22
Last Dividend
INR 4
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
189.16%
1Y total return
81.09%
200-day SMA
899
3Y total return
730.24%
50-day SMA
957.4
50-day SMA vs 200-day SMA
50over200
5Y total return
261.24%
All Time High
1,675
All Time High Change
-30.21%
All Time High Date
2024-10-17
All Time Low
50
All Time Low Change
2,238%
All Time Low Date
2001-07-19
ATR
38.97
Beta
0.31
Beta1y
0.39
Beta2y
0.33
Ch YTD
29.84
High
1,169.8
High52
1,169.8
High52 Date
2026-05-08
High52ch
0%
Low
1,144
Low52
615
Low52 Date
2025-05-09
Low52ch
90.08%
Ma50ch
22.11%
Price vs 200-day SMA
30.04%
RSI
75.83
RSI Monthly
62.6
RSI Weekly
72.77
Sharpe ratio
1.6x
Sortino ratio
2.92
Total Return
0.12%
Tr YTD
29.84
Tr15y
2,100.31%
Tr1m
17.59%
Tr1w
13.33%
Tr3m
35.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 7B
Operating Income Growth
-5.34
Operating Income Growth Q
14.48
Operating Income Growth3 Y
98.82
Operating Income Growth5 Y
14.09
Operating margin
14.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
56,697,428%
Shares Insiders
7.28%
Shares Institutions
29.87%
Shares Out
92,172,714
Shares Qo Q
0.06%
Shares Yo Y
0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Average Volume
306,970.8x
Bv Per Share
299.1
Ch10y
6.21
Ch15y
198.3
Ch1m
17.59
Ch1w
13.33
Ch1y
80.28
Ch20y
251.1
Ch3m
35.32
Ch3y
223.9
Ch5y
40.49
Ch6m
23.29
Change
1.94%
Change From Open
1.58
Close
1,146.8
Days Gap
0.35
Depreciation Amortization
1,470,825,000
Dollar Volume
304,470,726
Earnings Date
2026-05-22
EBIT
INR 7B
EBITDA
INR 8.5B
EPS
INR 55.49
F Score
1
Fiscal Year End
March
Founded
1,990
Graham Number
611.05077
Graham Upside
-47.73
Income Tax
INR 961.6M
Is Primary Listing
1
Last Earnings Date
2026-01-30
Last Report Date
2025-12-31
Lynch Fair Value
INR 1,387
Lynch Upside
18.67
Ma150
906.9
Ma150ch
28.9%
Ma20
1,042.5
Ma20ch
12.13%
Next Earnings Date
2026-05-22
Open
1,150.8
Payment Date
2025-09-06
Position In Range
96.9
Price Date
2026-05-08
Price EBITDA
INR 12.53
Ptbv Ratio
7.06
Relative Volume
0.84x
Revenue
47,256,060,000x
Tax By Revenue
2.03x
Tax Rate
15.34%
Tr20y
2,537.86%
Tr6m
23.29%
Volume
260,454
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/STAR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.3%
$4.00 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+9.9%
2 consecutive years of growth
Total shareholder yield
+0.1%
Next ex-dividend date: 2025-07-22
Performance

NSE/STAR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+81.1%
S&P 500 1Y: n/a
3Y total return
+730.2%
S&P 500 3Y: n/a
5Y total return
+261.2%
S&P 500 5Y: n/a
10Y total return
+189.2%
S&P 500 10Y: n/a
Ownership

Who owns NSE/STAR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+29.9%
Share of float held by funds and institutions
Insider ownership
+7.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

NSE/STAR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
75.8
Above 70: short-term overbought
Price vs 200-day MA
+30.0%
50/200-day relationship not available
Beta (5Y)
0.31
Less volatile than the market
Sharpe ratio
1.60
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/STAR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/STAR stock rating?

nse/STAR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/STAR analysis?

The full report lives at /stocks/nse/STAR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/STAR?

The latest report frames nse/STAR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/STAR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.